250 related articles for article (PubMed ID: 16007133)
1. RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation.
Wisdom R; Huynh L; Hsia D; Kim S
Oncogene; 2005 Oct; 24(47):7043-54. PubMed ID: 16007133
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
Hurta RA; Greenberg AH; Wright JA
J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
[TBL] [Abstract][Full Text] [Related]
4. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
Hurta RA; Lee J; Voskas D
J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
[TBL] [Abstract][Full Text] [Related]
5. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
Hurta RA; Wright JA
J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta 1 suppresses transformation in hepatocytes by regulating alpha 1 beta 1 integrin expression.
Serra R; Carbonetto S; Lord M; Isom HC
Cell Growth Differ; 1994 May; 5(5):509-17. PubMed ID: 8049157
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
Lo J; Hurta RA
Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.
Fensterer H; Giehl K; Buchholz M; Ellenrieder V; Buck A; Kestler HA; Adler G; Gierschik P; Gress TM
Genes Chromosomes Cancer; 2004 Mar; 39(3):224-35. PubMed ID: 14732924
[TBL] [Abstract][Full Text] [Related]
10. Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis.
Martínez-Salgado C; Fuentes-Calvo I; García-Cenador B; Santos E; López-Novoa JM
Exp Cell Res; 2006 Jul; 312(11):2093-106. PubMed ID: 16624289
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells.
Kim ES; Kim MS; Moon A
Cytokine; 2005 Jan; 29(2):84-91. PubMed ID: 15598443
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.
Vasseur S; Malicet C; Calvo EL; Dagorn JC; Iovanna JL
Mol Cancer; 2005 Jan; 4(1):4. PubMed ID: 15651998
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC.
Schmidt A; Lorkowski S; Seidler D; Breithardt G; Buddecke E
Eur J Clin Invest; 2006 Jul; 36(7):473-82. PubMed ID: 16796604
[TBL] [Abstract][Full Text] [Related]
14. Distinct pathways regulate transforming growth factor beta 1-stimulated proto-oncogene and extracellular matrix gene expression.
Howe PH; Cunningham MR; Leof EB
J Cell Physiol; 1990 Jan; 142(1):39-45. PubMed ID: 2153688
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells.
Mewani RR; Tian S; Li B; Danner MT; Carr TD; Lee S; Rahman A; Kasid UN; Jung M; Dritschilo A; Gokhale PC
Int J Mol Med; 2006 Mar; 17(3):457-63. PubMed ID: 16465392
[TBL] [Abstract][Full Text] [Related]
16. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.
Haddow S; Fowlis DJ; Parkinson K; Akhurst RJ; Balmain A
Oncogene; 1991 Aug; 6(8):1465-70. PubMed ID: 1886717
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
18. Reversion of Ras transformed cells by Ets transdominant mutants.
Wasylyk C; Maira SM; Sobieszczuk P; Wasylyk B
Oncogene; 1994 Dec; 9(12):3665-73. PubMed ID: 7970725
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of TGF-beta-induced tissue transglutaminase expression by PI3K-Akt pathway activation in human subconjunctival fibroblasts.
Jung SA; Lee HK; Yoon JS; Kim SJ; Kim CY; Song H; Hwang KC; Lee JB; Lee JH
Invest Ophthalmol Vis Sci; 2007 May; 48(5):1952-8. PubMed ID: 17460246
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells.
Kirwan RP; Leonard MO; Murphy M; Clark AF; O'Brien CJ
Glia; 2005 Dec; 52(4):309-24. PubMed ID: 16078232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
